Literature DB >> 12126626

The structures of crystalline complexes of human serum amyloid P component with its carbohydrate ligand, the cyclic pyruvate acetal of galactose.

D Thompson1, M B Pepys, I Tickle, S Wood.   

Abstract

Two monoclinic (P2(1)) crystal forms of human serum amyloid P component (SAP) in complex with the 4,6-pyruvate acetal of beta-D-galactose (MObetaDG) were prepared. Structure analysis by molecular replacement and refinement at 2.2A resolution revealed that crystal form 1 (a=95.76A, b=70.53A, c=103.41A, beta=96.80 degrees) contained a pentamer in the asymmetric unit with a structure very similar to that of the published search model. The mode of ligand co-ordination was also similar except that four of the five subunits showed bound ligand with an additional H-bond between O1 of the galactose and the side-chain of Lys79. One sub-unit showed no bound ligand and a vacant calcium site close to a crystal contact. The 2.6A resolution structure of crystal form 2 (a=118.60A, b=109.10A, c=120.80A and beta=95.16 degrees ) showed ten sub-units in the asymmetric unit, all with two bound calcium ions and ligand. The most extensive protein-protein interactions between pentamers describe an AB face-to-face interaction involving 15 ion pairs that sandwiches five molecules of bound MObetaDG at the interface.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126626     DOI: 10.1016/s0022-2836(02)00514-4

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

Review 1.  Amyloid accomplices and enforcers.

Authors:  Andrei T Alexandrescu
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

2.  Surface induced dissociation yields substructure of Methanosarcina thermophila 20S proteasome complexes.

Authors:  Xin Ma; Joseph A Loo; Vicki H Wysocki
Journal:  Int J Mass Spectrom       Date:  2015-02-01       Impact factor: 1.986

3.  Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology.

Authors:  Jeffrey R Crawford; Nicole L Bjorklund; Giulio Taglialatela; Richard H Gomer
Journal:  Neurochem Res       Date:  2011-12-29       Impact factor: 3.996

4.  Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques.

Authors:  Chiara Mencarelli; Gerard H Bode; Mario Losen; Mahesh Kulharia; Peter C Molenaar; Robert Veerhuis; Harry W M Steinbusch; Marc H De Baets; Gerry A F Nicolaes; Pilar Martinez-Martinez
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 5.  Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors.

Authors:  Terry W Du Clos; Carolyn Mold
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

6.  Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.

Authors:  Emma R Job; Barbara Bottazzi; Brad Gilbertson; Kathryn M Edenborough; Lorena E Brown; Alberto Mantovani; Andrew G Brooks; Patrick C Reading
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

Review 7.  Convergent and divergent mechanisms of sugar recognition across kingdoms.

Authors:  Maureen E Taylor; Kurt Drickamer
Journal:  Curr Opin Struct Biol       Date:  2014-08-05       Impact factor: 6.809

Review 8.  The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression.

Authors:  Zeyu Wang; Xing Wang; Hecun Zou; Ziyu Dai; Songshan Feng; Mingyu Zhang; Gelei Xiao; Zhixiong Liu; Quan Cheng
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.